The Transplant Society Congress took place from September 13th-16th, and gathered the latest science and innovations in the field of transplantation worldwide. More than 3,000 scientists, researchers and physicians representing over 130 countries attended from their homes and workspaces globally. Presentations covered basic, translational and clinical research, ethics, and emerging and disruptive technologies.
Originally scheduled to take place in Seoul, Korea, TTS canceled the in-person Congress due to the COVID-19 pandemic. To ensure continuity of education, ease and equal access to research, and to continue to further advance the field, the TTS President and the Scientific Program Chairs worked closely to change to a Virtual Congress, to virtually bring together the international transplant professional community.
Biohope participated in this Virtual Congress and presented the abstract “Analysis of Immunobiogram pharmacodynamic dose-response curves to immunosuppressants in kidney transplant recipients: Further results from Transbio Study.”, where it is shown that “in kidney transplanted patients, the dose-response curves of the inhibitory effect of immunosuppressive drugs over patients´ lymphocytes proliferation and activation obtained in vitro with IMBG are significantly associated with the clinical outcome.”